Novoray Past Earnings Performance
Past criteria checks 4/6
Novoray has been growing earnings at an average annual rate of 19.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 19.1% per year. Novoray's return on equity is 16.2%, and it has net margins of 26.2%.
Key information
19.4%
Earnings growth rate
16.9%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 19.1% |
| Return on equity | 16.2% |
| Net Margin | 26.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Market Participants Recognise Novoray Corporation's (SHSE:688300) Earnings Pushing Shares 34% Higher
Oct 18
These 4 Measures Indicate That Novoray (SHSE:688300) Is Using Debt Safely
Oct 16What Does Novoray Corporation's (SHSE:688300) Share Price Indicate?
Sep 26If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity
Aug 20Novoray's (SHSE:688300) Returns On Capital Not Reflecting Well On The Business
Jul 29What Novoray Corporation's (SHSE:688300) P/E Is Not Telling You
Jul 13Why Novoray Corporation (SHSE:688300) Could Be Worth Watching
Jun 19If EPS Growth Is Important To You, Novoray (SHSE:688300) Presents An Opportunity
May 13Does Novoray (SHSE:688300) Have A Healthy Balance Sheet?
Apr 23Novoray's (SHSE:688300) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Apr 01Earnings Miss: Novoray Corporation Missed EPS By 8.5% And Analysts Are Revising Their Forecasts
Mar 28Subdued Growth No Barrier To Novoray Corporation (SHSE:688300) With Shares Advancing 28%
Mar 01When Should You Buy Novoray Corporation (SHSE:688300)?
Feb 27Revenue & Expenses Breakdown
How Novoray makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 895 | 234 | 66 | 56 |
| 30 Jun 24 | 841 | 218 | 65 | 55 |
| 31 Mar 24 | 769 | 197 | 61 | 51 |
| 31 Dec 23 | 712 | 174 | 59 | 47 |
| 30 Sep 23 | 685 | 182 | 60 | 45 |
| 30 Jun 23 | 625 | 169 | 57 | 39 |
| 31 Mar 23 | 630 | 174 | 55 | 38 |
| 31 Dec 22 | 662 | 188 | 51 | 38 |
| 30 Sep 22 | 657 | 175 | 47 | 38 |
| 30 Jun 22 | 686 | 186 | 45 | 40 |
| 31 Mar 22 | 663 | 179 | 46 | 38 |
| 31 Dec 21 | 625 | 173 | 46 | 35 |
| 30 Sep 21 | 581 | 169 | 49 | 30 |
| 30 Jun 21 | 522 | 147 | 49 | 26 |
| 31 Mar 21 | 473 | 130 | 44 | 24 |
| 31 Dec 20 | 404 | 111 | 44 | 20 |
| 30 Sep 20 | 367 | 92 | 46 | 19 |
| 30 Jun 20 | 341 | 82 | 45 | 16 |
| 31 Mar 20 | 321 | 78 | 50 | 13 |
| 31 Dec 19 | 315 | 75 | 48 | 13 |
| 30 Sep 19 | 298 | 69 | 43 | 12 |
| 30 Jun 19 | 292 | 67 | 41 | 12 |
| 31 Mar 19 | 277 | 60 | 38 | 11 |
| 31 Dec 18 | 278 | 58 | 38 | 11 |
| 30 Sep 18 | 264 | 54 | 37 | 10 |
| 30 Jun 18 | 249 | 50 | 37 | 10 |
| 31 Mar 18 | 230 | 46 | 34 | 9 |
| 31 Dec 17 | 211 | 42 | 32 | 8 |
| 30 Sep 17 | 193 | 41 | 31 | 6 |
| 30 Jun 17 | 176 | 39 | 31 | 3 |
| 31 Mar 17 | 165 | 36 | 32 | 2 |
| 31 Dec 16 | 154 | 33 | 33 | 0 |
| 30 Sep 16 | 143 | 27 | 32 | 0 |
| 30 Jun 16 | 132 | 20 | 31 | 0 |
| 31 Mar 16 | 127 | 19 | 30 | 0 |
| 31 Dec 15 | 122 | 18 | 30 | 0 |
| 30 Sep 15 | 121 | 19 | 29 | 0 |
| 30 Jun 15 | 132 | 20 | 29 | 0 |
| 31 Mar 15 | 131 | 19 | 30 | 0 |
| 31 Dec 14 | 125 | 19 | 30 | 0 |
| 31 Dec 13 | 120 | 14 | 30 | 0 |
Quality Earnings: 688300 has high quality earnings.
Growing Profit Margin: 688300's current net profit margins (26.2%) are lower than last year (26.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688300's earnings have grown by 19.4% per year over the past 5 years.
Accelerating Growth: 688300's earnings growth over the past year (28.7%) exceeds its 5-year average (19.4% per year).
Earnings vs Industry: 688300 earnings growth over the past year (28.7%) exceeded the Chemicals industry -5.3%.
Return on Equity
High ROE: 688300's Return on Equity (16.2%) is considered low.